Combining the estrogen hormone estriol with Copaxone, a drug indicated for the treatment of patients with relapsing forms of multiple sclerosis (MS), may improve symptoms in MS patients. This is according to preliminary results from a clinical study of 158 patients with relapsing remitting multiple sclerosis (RRMS). The findings were presented by Rhonda Voskuhl, M.D., from the University of California, Los Angeles, at the American Academy of Neurology Annual Meeting ...
Read MoreYou have just read an article categorized health
titled Preliminary Results of a Clinical Study Shows Improvement in Multiple Sclerosis Symptoms.
Written by:
editor - Wednesday, April 30, 2014
There are currently no comments for "Preliminary Results of a Clinical Study Shows Improvement in Multiple Sclerosis Symptoms"
Post a Comment